Aldeyra Claims Success In Final Phase III For First-In-Class Dry Eye Drug

Both Co-Primary Endpoints Hit In TRANQUILITY-2

 
• By Jessica Merrill
eye dropper
Aldeyra is developing a new eye drug • Source: Shutterstock

More from Clinical Trials

More from R&D